Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1Head & Neck 1Gynecologic 1Genitourinary 1Dermatologic 1Breast 1

Conditions

Carcinoma, Renal Cell 9Prostatic Neoplasms 8Urinary Bladder Neoplasms 7Melanoma 7Neoplasms 5Head and Neck Neoplasms 5Carcinoma, Non-Small-Cell Lung 5Ovarian Neoplasms 4Breast Neoplasms 4Uterine Cervical Neoplasms 3Triple Negative Breast Neoplasms 3Stomach Neoplasms 3Pancreatic Neoplasms 3Neoplasm Metastasis 3Colorectal Neoplasms 3Carcinoma, Merkel Cell 3Squamous Cell Carcinoma of Head and Neck 2Kidney Neoplasms 2Colonic Neoplasms 2Carcinoma, Hepatocellular 2Uveal Melanoma 1Uterine Neoplasms 1Thyroid Neoplasms 1Small Cell Lung Carcinoma 1Skin Neoplasms 1Sarcoma 1Recurrence 1Penile Neoplasms 1Mesothelioma, Malignant 1Lymphoma, Non-Hodgkin 1

Interventions

pembrolizumab 1enzalutamide 1cemiplimab 1abiraterone 1Stents 1Nephrotomy 1Nephrostomy, Percutaneous 1Immune Checkpoint Inhibitors 1Etanercept 1Cytochrome P-450 Enzyme System 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Bites and Stings × cemiplimab × Genitourinary × Clear all
NCT06022029 2025-12-24

ON-5001

OncoNano Medicine, Inc.

Phase 1 Recruiting
168 enrolled
BreastDermatologicGenitourinaryGynecologicHead & NeckLymphoid

Squamous Cell Carcinoma of Head and Neck, Uveal Melanoma, Bites and Stings, Urinary Bladder Neoplasms, Breast Neoplasms, Carcinoma in Situ, Uterine Cervical Neoplasms, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Melanoma, Neoplasm Metastasis, Neoplasms, Recurrence, Skin Neoplasms, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Mantle-Cell, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡